By Wallace Witkowski and Victor Reklaitis, MarketWatch
SAN FRANCISCO (MarketWatch) -- Cyberonics Inc. shares declined in the extended session Monday after the medical device maker said its appeal of a medical reimbursement decision was denied.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.